C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/1999
12/29/1999	WO1999067294A1 Antigenic complex comprising immunostimulatory peptide, cd4, and chemokine receptor domain for hiv treatment and immune disorders
12/29/1999	WO1999067292A1 MODIFIED GnRH RECEPTOR
12/29/1999	WO1999067291A2 Site specific protein modification by mutagenesis
12/29/1999	WO1999067290A1 Novel hemopoietin receptor proteins
12/29/1999	WO1999067289A1 A method for inducing production of growth factors
12/29/1999	WO1999067287A1 A spray-dried bacteriocin powder with anti-microbial activity
12/29/1999	WO1999067286A2 Novel staphylococcus peptides for bacterial interference
12/29/1999	WO1999067285A1 Particles of hcv envelope proteins: use for vaccination
12/29/1999	WO1999067284A2 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
12/29/1999	WO1999067282A2 Olfactory receptors and their uses
12/29/1999	WO1999067277A1 Method and apparatus for the production of purified plasma proteins
12/29/1999	WO1999067269A1 Nucleic acid molecule encoding an ankyrin repeat tvl-1 protein and methods of use thereof
12/29/1999	WO1999066959A2 Compositions and methods for delivery of genetic material for altering neuronal growth, regeneration, and survival
12/29/1999	WO1999066957A2 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens
12/29/1999	WO1999066956A1 IMMUNOLOGICAL AGENTS SPECIFIC FOR PRION PROTEIN (PrP)
12/29/1999	WO1999066954A1 Synthetic peptide vaccines for foot-and-mouth disease
12/29/1999	WO1999066952A1 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic lhrh peptides
12/29/1999	WO1999066950A1 Synthetic somatostatin immunogen for growth promotion in farm animals
12/29/1999	WO1999066946A1 Compositions and methods for inducing apoptosis in e6-expressing cells
12/29/1999	WO1999066875A2 Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism
12/29/1999	WO1999058681A3 Transgenic plant cells expressing a recombinant plant e2f peptide
12/29/1999	WO1999058640A3 Mct-1, a human oncogene
12/29/1999	WO1999058639A3 Structural proteins of fish pancreatic disease virus and uses thereof
12/29/1999	WO1999058563A3 Moraxella catharralis proteins
12/29/1999	WO1999057284A3 Attenuated influenza viruses
12/29/1999	WO1999057140A3 Growth-associated protease inhibitor heavy chain precursor
12/29/1999	WO1999055908A3 Nucleotide sequences for detecting enterohemorrhagic escherichia coli (ehec)
12/29/1999	WO1999054436A3 Nucleic acids and proteins of c. elegans insulin-like genes and uses thereof
12/29/1999	WO1999054360A8 Substance with antithrombotic activity and method for detecting glycokallidin
12/29/1999	WO1999051779A3 Glaucoma therapeutics and diagnostics
12/29/1999	WO1999051626A3 Template associated npy y2-receptor agonists
12/29/1999	WO1999045950A3 Methods of suppressing microglial activation
12/29/1999	WO1999043802A3 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
12/29/1999	WO1999041390A8 Expression vector for the production of dead proteins
12/29/1999	WO1997040147A8 Antigenically reactive regions of the hepatitis a virus polyprotein
12/29/1999	EP0967289A1 Improvements in gene therapy using compositions comprising a polynucleotide and a nuclease inhibitor
12/29/1999	EP0967280A1 Yeast strains with fil phenotype, stress resistant under conditions of growth and/or fermentation
12/29/1999	EP0967279A1 Helicobacter pylori cytotoxin useful for vaccines and diagnostics
12/29/1999	EP0967278A2 Flowering regulating gene and its use
12/29/1999	EP0967276A2 Anti-tumor agent comprising salmosin
12/29/1999	EP0967226A2 Methods for the production of fibrillar collagen
12/29/1999	EP0967225A1 ATP-sensitive potassium channel gene (Kir6.2/BIR)-deficient animals
12/29/1999	EP0967224A1 Novel protein, its gene, reagents for inducing apoptosis, and anticancer agents
12/29/1999	EP0967223A2 Hepatitis C virus peptide antigens and a method of testing for the hepatitis C virus (HCV)
12/29/1999	EP0966975A2 Diagnostic agents for pancreatic exocrine function
12/29/1999	EP0966685A1 Protein fragment complementation assays to detect biomolecular interactions
12/29/1999	EP0966545A2 Method for typing of minor histocompatibility antigen ha-1
12/29/1999	EP0966538A1 Replication-competent recombinant sabin type 1 strain of poliovirus
12/29/1999	EP0966536A1 Factor x analogues with a modified protease cleavage site
12/29/1999	EP0966535A1 Epitopes of the protein pre-m/m of the dengue virus, synthetic peptides
12/29/1999	EP0966534A1 Compositions and methods for elimination of unwanted cells
12/29/1999	EP0966533A1 Activity dependent neurotrophic factor iii (adnf iii)
12/29/1999	EP0966531A1 Tazarotene-induced gene 3 (tig3)
12/29/1999	EP0966530A2 Secreted proteins and polynucleotides encoding them
12/29/1999	EP0966484A1 Neurotactin and uses therefor
12/29/1999	EP0966483A1 Beta-endorphin peptides for treating muscle-wasting diseases
12/29/1999	EP0966482A1 Crystallisation of proteins
12/29/1999	EP0966481A2 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
12/29/1999	EP0966480A2 Cysteine-depleted peptides recognized by a3-restricted cytotoxic lymphocytes, and uses therefor
12/29/1999	EP0966478A1 Novel hedgehog-derived polypeptides
12/29/1999	EP0966297A1 Methods for regulating gastrointestinal motility
12/29/1999	EP0966296A1 Conjugated peptides, immunological reagent containing same and use thereof for treatment of immunological disorders
12/29/1999	EP0966206A2 Frozen food product containing antifreeze peptides
12/29/1999	EP0966197A1 Plasmin-depletion therapy
12/29/1999	EP0851922B1 Cyclin depenpent kinase binding compounds
12/29/1999	EP0822993B1 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene kai1
12/29/1999	EP0774005B1 Surface expression of enzyme in gene directed prodrug therapy
12/29/1999	EP0668781B1 Lymphokine gene therapy of cancer in combination with tumor antigens
12/29/1999	EP0635062B1 METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS OF mRNA
12/29/1999	EP0625048B1 Synthesis of human procollagens and collagens in recombinant dna systems
12/29/1999	EP0614372B1 Antiviral factor from cd8+ cells
12/29/1999	EP0556292B1 Hepatitis c virus asialoglycoproteins
12/29/1999	CN1240028A Assay for detection of antibodies against P53
12/29/1999	CN1240002A Strain belonging to genus bacillus and insecticidal proteins
12/29/1999	CN1240001A Mutants of streptococcal toxin C and methods of use
12/29/1999	CA2336102A1 Absorptive hypercalciuria locus on human chromosome 1
12/29/1999	CA2335804A1 Allelic series of genomic modifications in cells
12/29/1999	CA2335585A1 Novel molecules of the t110-related protein family and uses thereof
12/29/1999	CA2334645A1 Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism
12/29/1999	CA2331924A1 Propionibacterium vector
12/29/1999	CA2331923A1 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses
12/29/1999	CA2331921A1 A novel invertebrate intestinal mucin cdna and related products and methods
12/29/1999	CA2331888A1 Novel staphylococcus peptides for bacterial interference
12/29/1999	CA2331769A1 Prostate cancer-associated genes
12/29/1999	CA2331200A1 Olfactory receptors and their uses
12/29/1999	CA2331152A1 Cell cycle regulating factor
12/29/1999	CA2330921A1 A screening system for agonists
12/29/1999	CA2330547A1 Novel hemopoietin receptor proteins
12/29/1999	CA2330542A1 Human arf-related proteins
12/29/1999	CA2330526A1 Particles of hcv envelope proteins: use for vaccination
12/29/1999	CA2330249A1 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic lhrh peptides
12/29/1999	CA2330189A1 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore
12/29/1999	CA2330178A1 Synthetic peptide vaccines for foot-and-mouth disease
12/29/1999	CA2330026A1 Compositions and methods for delivery of agents for altering neuronal growth, regeneration, and survival
12/29/1999	CA2329939A1 Transgenetic non-human animal which comprises an inactive peg3 gene, and the use thereof
12/29/1999	CA2329755A1 Synthetic somatostatin immunogen for growth promotion in farm animals
12/29/1999	CA2328457A1 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
12/28/1999	US6008436 Plant cells with a heterologous dna construct comprising a transcription cassette, in the 5' to 3' direction a promoter and dna encoding a nematode-inducible transmembrane pore protein; parasiticides
12/28/1999	US6008435 Detecting cow, sheep and human prions in a sample and transgenic mice used for same
12/28/1999	US6008434 Rodents with mutated endogenous growth differentiation factor-11 gene; animals exhibiting a phenotype of increased muscle tissue; animal food products with high muscle and protein content, reduced fat and cholesterol

1 ... 2208 2209 2210 2211 2212 2213 2214 2215 2216 2217 2218 2219 2220 2221 2222 2223 2224 2225 2226 2227 2228 ... 2916